Wockhardt received tentative approval for the Abbreviated New Drug Application from the US FDA for the Fexofenadine Hydrochloride oral tablets in multiple strengths of 30 mg, 60 mg and 180 mg.
133645
Wockhardt received tentative approval for the Fexofenadine Hydrochloride
86159
Forest Laboratories acquires rights to antiarrhythmic agent
130150
FDA approves first cord blood product
55099
FDA announces limited return of heartworm drug for dogs
66069
Targacept publicly offering 2.2 million shares
90428
Glaxo beats expectations
56218
Ranbaxy launches cevimeline hydrochloride capsules in US market
157512
FDA approves vaccines for the 2010-2011 influenza season
24157
Medsafe reviewing two pain medicines
17962
US Food and drug Administration issues complete response letter regarding
49985
Endosense launches TOCCATA clinical study
127668
Javelin Pharmaceuticals, Inc. comments on tender offer extension by Hospira
61307
Advantest's terahertz spectroscopic/imaging system TAS7500 adopted by Astellas Pharma Inc.
134739
Watson Pharmaceuticals receives FDA approval for oral contraceptive product
93858
Novartis receives approval in the European Union for Menveo®, first quadrivalent conjugate vaccine in the
49489
Pfizer arthritis drug meets main goals of trial
98125
Oral drops provide a safe and effective alternative for allergy sufferers